{"id":18068,"date":"2026-04-08T15:07:42","date_gmt":"2026-04-08T19:07:42","guid":{"rendered":"https:\/\/www.biotech.ca\/?post_type=tribe_events&p=18068"},"modified":"2026-04-08T15:07:42","modified_gmt":"2026-04-08T19:07:42","slug":"life-sciences-nova-scotia-sred-after-royal-assent-what-life-sciences-companies-need-to-do-now","status":"publish","type":"tribe_events","link":"https:\/\/www.biotech.ca\/fr\/event\/life-sciences-nova-scotia-sred-after-royal-assent-what-life-sciences-companies-need-to-do-now\/","title":{"rendered":"Life Sciences Nova Scotia – SR&ED After Royal Assent: What Life Sciences Companies Need to Do Now"},"content":{"rendered":"
Overview<\/div>\n
<\/div>\n
Learn what’s changed in the federal SR&ED program and how it could impact your company before your next year end<\/div>\n
\n
\n
\n

About This Event<\/strong><\/h4>\n

This 60-minute webinar will walk companies through what changed in Scientific Research and Experimental Development tax credits (SR&ED) now that the federal budget has received Royal Assent. Our guest speakers, tax and funding experts from Ryan, will cover what this change means for your projects and cash flow, and help you understand the impact to your business.<\/p>\n

Objectives<\/strong><\/h4>\n

By the end of the webinar, participants should be able to:<\/strong><\/p>\n

\u2022<\/strong>\u00a0Identify the key SR&ED legislative and administrative changes triggered when the budget receives Royal Assent.<\/p>\n

\u2022 Understand how those changes affect eligibility, rates, and documentation for typical life sciences R&D projects.<\/p>\n

\u2022 Adjust their year end and multi year non dilutive funding strategy in light of the new rules.<\/p>\n

\u2022 Know the immediate action items for claims in the current and next fiscal year.<\/p>\n

________________________________________<\/strong><\/p>\n

Agenda (60 minutes)<\/strong><\/p>\n

1. Welcome and context (5 min)<\/strong><\/p>\n

\u2022 Brief intro from Life Sciences Nova Scotia and PEI BioAlliance on why SR&ED matters locally.<\/p>\n

\u2022 Introduce Ryan and experience with SR&ED and life sciences clients.<\/p>\n

2. Refresher on SR&ED (15 min)<\/strong><\/p>\n

\u2022 Overview of SR&ED basics: purpose, federal vs provincial mechanics, credit rates.<\/p>\n

\u2022 Typical life sciences claim structure: eligible work, expenditures, and documentation.<\/p>\n

\u2022 Common pitfalls and misconceptions before the legislative changes.<\/p>\n

3. What just changed in SR&ED? (10 min)<\/strong><\/p>\n

\u2022<\/strong>\u00a0Key measures triggered by Royal Assent.<\/p>\n

\u2022 Updates to eligibility, expenditure rules, and administrative requirements.<\/p>\n

4. Implications for life sciences companies (10 min)<\/strong><\/p>\n

\u2022 How new rules affect various R&D types: clinical\/pre clinical, digital health, AI\/ML, and manufacturing scale up.<\/p>\n

\u2022 Sample financial impacts comparing old vs new credit outcomes.<\/p>\n

\u2022 Coordination with IRAP, provincial programs, and grants.<\/p>\n

5. Year end and planning checklist (10 min)<\/strong><\/p>\n

\u2022 Practical steps for current and next fiscal years.<\/p>\n

\u2022 Handling projects spanning the change and maintaining compliant documentation.<\/p>\n

\u2022 \u201cDo and don\u2019t\u201d highlights for the next 6\u201312 months.<\/p>\n

6. Q&A and next steps (20 min)<\/strong><\/p>\n

\u2022 Open Q&A with emphasis on submitted questions (e.g., clinical trials, CRA reviews, negative decisions).<\/p>\n

\u2022 Invitation for attendees to book 1 on 1 follow up meetings via calendar link.<\/p>\n

About the Organizers<\/strong><\/p>\n

Life Sciences Nova Scotia is a not-for-profit industry association focused on demonstrating the unique position and potential of Nova Scotia as a burgeoning life sciences region.<\/p>\n

The PEI BioAlliance is a private sector led organization that coordinates and grows Prince Edward Island\u2019s bioscience cluster and strengthens collaboration across Atlantic Canada\u2019s life sciences ecosystem.<\/p>\n

Ryan is a global tax services firm that helps life sciences and other companies unlock tax credits and non-dilutive funding through strategic, year-round support.<\/p>\n

Registration is free and open until the event begins. Secure your spot today!<\/p>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Overview Learn what’s changed in the federal SR&ED program and how it could impact your company before your next year end About This Event This 60-minute webinar will walk companies<\/p>\n

Lire la suite<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","template":"","meta":{"_acf_changed":false,"rank_math_lock_modified_date":false,"inline_featured_image":false,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","_tribe_events_status":"","_tribe_events_status_reason":"","_tribe_events_is_hybrid":"","_tribe_events_is_virtual":"","_tribe_events_virtual_video_source":"","_tribe_events_virtual_embed_video":"","_tribe_events_virtual_linked_button_text":"","_tribe_events_virtual_linked_button":"","_tribe_events_virtual_show_embed_at":"","_tribe_events_virtual_show_embed_to":[],"_tribe_events_virtual_show_on_event":"","_tribe_events_virtual_show_on_views":"","_tribe_events_virtual_url":"","footnotes":""},"tags":[],"tribe_events_cat":[68,30],"class_list":["post-18068","tribe_events","type-tribe_events","status-publish","tribe_events_cat-member-event","tribe_events_cat-virtual","cat_member-event","cat_virtual","entry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.biotech.ca\/fr\/wp-json\/wp\/v2\/tribe_events\/18068","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.biotech.ca\/fr\/wp-json\/wp\/v2\/tribe_events"}],"about":[{"href":"https:\/\/www.biotech.ca\/fr\/wp-json\/wp\/v2\/types\/tribe_events"}],"author":[{"embeddable":true,"href":"https:\/\/www.biotech.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.biotech.ca\/fr\/wp-json\/wp\/v2\/comments?post=18068"}],"version-history":[{"count":1,"href":"https:\/\/www.biotech.ca\/fr\/wp-json\/wp\/v2\/tribe_events\/18068\/revisions"}],"predecessor-version":[{"id":18069,"href":"https:\/\/www.biotech.ca\/fr\/wp-json\/wp\/v2\/tribe_events\/18068\/revisions\/18069"}],"wp:attachment":[{"href":"https:\/\/www.biotech.ca\/fr\/wp-json\/wp\/v2\/media?parent=18068"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.biotech.ca\/fr\/wp-json\/wp\/v2\/tags?post=18068"},{"taxonomy":"tribe_events_cat","embeddable":true,"href":"https:\/\/www.biotech.ca\/fr\/wp-json\/wp\/v2\/tribe_events_cat?post=18068"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}